Predictive Nomogram for Recurrence After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2)
: This study identified the prognostic risk factors for recurrence and developed a recurrence prediction model for patients undergoing UFS for rPDAC. Moreover, a recurrence-free interval of five months was identified as the optimal threshold for distinguishing between early and late recurrences.
Authors
- Kenta Sui (ORCID: https://orcid.org/0009-0009-5441-6005)
- Takehiro Okabayashi (ORCID: https://orcid.org/0000-0002-4829-4306)
- Daisuke Nobuoka (ORCID: https://orcid.org/0000-0001-9955-6284)
- Tatsuo Matsuda
- Kosei Takagi (ORCID: https://orcid.org/0000-0003-2267-2441)
- Susumu Shinoura (ORCID: https://orcid.org/0000-0002-4054-7778)
- Toru Kojima (ORCID: https://orcid.org/0000-0002-4460-7520)
- Yoshikatsu Endo
- Masayoshi Hioki
- Masaru Inagaki
- Hideki Aoki
- Ryuichi Yoshida
- Kazuya Yasui
- Masashi Kimura
Institutions
- Okayama University (JP)
- CHI Health (US)
- Matsuyama Shimin Hospital (JP)
- Okayama University Hospital (JP)
- Fukuyama City Hospital (JP)
- Tsuyama Chuo Hospital (JP)
- Fukuyama Cardiovascular Hospital (JP)
- Iwakuni Medical Center (JP)
- Himeji Red Cross Hospital (JP)
- Kagawa University Hospital (JP)
- Okayama Saiseikai General Hospital (JP)
- Kagawa Prefectural Central Hospital (JP)
Publication Details
- Journal
- Cancers
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/cancers18071181
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- NIH Clinical Center